-
Jul 18 |
Diagnostics World | Swiss researchers have achieved a significant breakthrough in cancer diagnostics, demonstrating that advanced multiomics testing can successfully predict the most effective treatments for melanoma patients within four weeks—a timeline fast enough for real-world clinical use.
More
-
Jul 17 |
Diagnostics World | A study has revealed that phosphorylated tau (p-tau217), a key biomarker for Alzheimer's disease diagnosis, appears at even higher levels in healthy newborns than in adults with Alzheimer's disease—a finding that could reshape how clinicians interpret this widely-used diagnostic tool.
More
-
Jul 10 |
Diagnostics World | A growing number of promising young companies are developing tests that are particularly good at picking up early cancer, initially for a single type of cancer but with the potential to eventually be extended to multiple cancer types. A handful of these startups will be spotlighted at the upcoming Next Generation Dx Summit .
More
-
Jul 09 |
Diagnostics World | Molecular testing for minimal residual disease (MRD) is increasingly being used to detect cancer recurrence, and to that end many companies are actively developing assays. The tumor-informed approach based on the genetic mutations of patients has been particularly popular and often employs cell-free DNA (cfDNA) and more specifically circulating tumor DNA (ctDNA) analysis.
More
-
Jul 08 |
Diagnostics World | Researchers at the University of Chicago have published a new approach to cancer detection offering early unprecedented accuracy in identifying both early and late-stage cancers through a simple blood plasma test. The results were published today in a Brief Communication in Nature Biotechnology
More
-
Jul 03 |
Diagnostics World | For patients who suffer negative health consequences from a delayed diagnosis, new-to-the-scene digital microfluidics (DMF) technology for multifunctional testing can literally save lives. A standout in the field is Baebies (Durham, North Carolina), which has developed a pair of such platforms cleared by the U.S. Food and Drug Administration (FDA) intended for rapid point-of-care testing to aid diagnostic testing in newborns.
More
-
Jul 01 |
Diagnostics World | For patients who suffer negative health consequences from a delayed diagnosis, new-to-the-scene digital microfluidics (DMF) technology for multifunctional testing can literally save lives. A standout in the field is Baebies (Durham, North Carolina), which has developed a pair of such platforms cleared by the U.S. Food and Drug Administration (FDA) intended for rapid point-of-care testing to aid diagnostic testing in newborns.
More
-
Jun 26 |
Diagnostics World | Galatea Bio and Fabric Genomics announced a strategic collaboration this week to enhance genetic testing by incorporating both rare pathogenic variant analysis and polygenic risk scoring (PRS) to assess genetic susceptibility to common diseases.
More
-
Jun 25 |
Diagnostics World | Elkedonia SAS plans to develop the drug-like small molecule inhibitors of Elk1, a novel intracellular target that plays a pivotal role in reward brain circuits and neuroplasticity; SpliceBio will advance the clinical development of their lead gene therapy candidate, SB-007, for Stargardt disease; and more.
More
-
Jun 24 |
Diagnostics World | Veeva and Sarah Cannon Research Institute has entered a strategic collaboration; City of Hope was awarded an up to $23.7 million contract from the Advanced Research Projects Agency for Health within the US Department of Health and Human Services; and more.
More
-
Sep 25 |
PRINCETON, NJ - Sep 25, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced that the US Food and Drug Administration (FDA) has renewed its legacy licenses for Synchrogenixs electronic Common Technical Document (eCTD) review software, GlobalSubmit REVIEW and GlobalSubmit VALIDATE for another year
More
-
Sep 24 |
PHILADELPHIA, PA, UNITED STATES - Sep 24, 2019 - Proscia, a leading provider of digital pathology software, has been granted U.S. Patent No. 10,346,980 by the United States Patent and Trademark Office (USPTO)
More
-
Sep 24 |
ROYSTON, UK - Sep 24, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has joined UK Medicines Discovery Catapults Discovery Services Platform, partnering with other best-in-class service providers to help improve preclinical drug discovery success rates
More
-
Sep 17 |
, UK - Sep 17, 2019 - QuantuMDx Group Limited, a UK-based life sciences company developing transformational point of care diagnostics, is pleased to announce Neil Butler has joined its Board as an Independent Non-Executive Director
More
-
Sep 17 |
PRINCETON, NJ - Sep 17, 2019 - The WIRB-Copernicus Group®s (WCG) Clinical Services Division is pleased to announce that enrollment in WCG KMR Groups 2019 Clinical Trial Cost Study is now open
More
-
Sep 17 |
PRINCETON, NJ - Sep 17, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the launch of Hasharc, its decentralized application (DApp) for healthcare, built in conjunction with the Hedera public Distributed Ledger Technology (DLT)
More
-
Sep 12 |
HONOLULU, HI, UNITED STATES - Sep 13, 2019 - Honolulu, HI (September 13, 2019) - A recently released workforce supply and demand study conducted by the Healthcare Association of Hawaii (HAH) reveals a need for phlebotomists in the state
More
-
Sep 12 |
CAMBRIDGE, MA - Sep 12, 2019 - Shimmer Research, a global leader in wearable technology for research applications, today announced the launch of a healthcare industry open source initiative for wearable sensor algorithms
More
-
Sep 12 |
PRINCETON, NJ - Sep 12, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the launch of Phoenix® 8
More
-
Sep 11 |
ROYAL OAK, MI, UNITED STATES - Sep 11, 2019 - OncoCell MDx, Inc., a pan-disease immunogenomics platform company developing novel noninvasive blood-based tests to optimize patient care, today announced it has raised $22
More
View more articles